Shagun Singh
Stock Analyst at RBC Capital
(2.51)
# 2,390
Out of 4,996 analysts
227
Total ratings
50.52%
Success rate
-0.93%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Initiates: Sector Perform | $211 | $184.60 | +14.30% | 1 | Sep 25, 2025 | |
| OM Outset Medical | Reiterates: Sector Perform | $22 | $14.48 | +51.93% | 13 | Aug 19, 2025 | |
| ISRG Intuitive Surgical | Reiterates: Outperform | $615 | $441.12 | +39.42% | 16 | Aug 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $112 → $115 | $98.24 | +17.06% | 16 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Outperform | $330 → $350 | $318.00 | +10.06% | 2 | Aug 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Outperform | $45 → $25 | $12.00 | +108.33% | 3 | Aug 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $215 → $180 | $77.24 | +133.04% | 6 | Aug 5, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $130 → $135 | $119.99 | +12.51% | 22 | Aug 1, 2025 | |
| PEN Penumbra | Maintains: Outperform | $330 → $325 | $253.37 | +28.27% | 15 | Jul 30, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $85 → $89 | $76.25 | +16.72% | 22 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $185 | $179.71 | +2.94% | 22 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.45 | +106.90% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $145 → $147 | $133.55 | +10.07% | 16 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $105 → $101 | $94.22 | +7.20% | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $116 → $120 | $98.18 | +22.22% | 16 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $369.02 | +17.88% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $55.70 | +65.17% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $67.10 | +71.39% | 4 | Oct 25, 2024 |
Becton, Dickinson and Company
Sep 25, 2025
Initiates: Sector Perform
Price Target: $211
Current: $184.60
Upside: +14.30%
Outset Medical
Aug 19, 2025
Reiterates: Sector Perform
Price Target: $22
Current: $14.48
Upside: +51.93%
Intuitive Surgical
Aug 19, 2025
Reiterates: Outperform
Price Target: $615
Current: $441.12
Upside: +39.42%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $112 → $115
Current: $98.24
Upside: +17.06%
Insulet
Aug 8, 2025
Maintains: Outperform
Price Target: $330 → $350
Current: $318.00
Upside: +10.06%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $12.00
Upside: +108.33%
Inspire Medical Systems
Aug 5, 2025
Maintains: Outperform
Price Target: $215 → $180
Current: $77.24
Upside: +133.04%
Teleflex
Aug 1, 2025
Maintains: Sector Perform
Price Target: $130 → $135
Current: $119.99
Upside: +12.51%
Penumbra
Jul 30, 2025
Maintains: Outperform
Price Target: $330 → $325
Current: $253.37
Upside: +28.27%
Edwards Lifesciences
Jul 25, 2025
Maintains: Outperform
Price Target: $85 → $89
Current: $76.25
Upside: +16.72%
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $179.71
Upside: +2.94%
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.45
Upside: +106.90%
Jul 15, 2025
Maintains: Outperform
Price Target: $145 → $147
Current: $133.55
Upside: +10.07%
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $94.22
Upside: +7.20%
Apr 24, 2025
Maintains: Outperform
Price Target: $116 → $120
Current: $98.18
Upside: +22.22%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $369.02
Upside: +17.88%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $55.70
Upside: +65.17%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $67.10
Upside: +71.39%